Ellagic Acid Clotting Time

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Ellagic Acid Clotting Time

Test Information:
Ellagic acid clotting time utilizes liquid purified soy and rabbit brain phosphatides with plasma activator. This results to an activated partial thromboplastin reagent with increased sensitivity to lupus-like inhibitors for use in the determination of the activated partial thromboplastin time (APTT) and related coagulation procedures.

Specimen Container:
Blue Top Tube (Sodium Citrate)

Specimen Type:
Plasma

Required Volume:
2 mL

Patient Preparation:
No Patient Preparation

Notes:
To obtain optimal results, it is recommended to separate plasma from whole blood within 1 hour from the time of collection; aliquoted specimen must be transported within 4 hours from the time of collection.

  • For aliquoted specimen, DO NOT USE GLASS TUBE CONTAINER.
  • Specimen received beyond the stipulated storage and stability is considered “sub-optimal” in nature.

Storage & Stability
(Before Processing)

  • Storage: 15 to 25°C
    Stability: 4 hours

Transport Temperature:
Room (18°C – 24°C)

Test Category:
Batch

Test Schedule:
Specimen receiving CUT-OFF:
Tuesday and Friday, 1100H

All specimen received beyond cut-off will be included for the next batch processing.

Results Availability:
Wednesday and Saturday, 1200H

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.